Cycurion, Inc. filed Amendment No. 1 to its Form S-1 registration statement with the U.S. Securities and Exchange Commission on November 10, 2026, covering the resale of up to 789,355 shares of common stock by selling stockholders.

Key Highlights

  • Total shares registered: Up to 789,355 shares of common stock, par value $0.0001 per share, are covered by this resale prospectus.
  • Three tranches: The shares consist of 626,520 shares underlying warrants held by Armistice Capital Master Fund Ltd., 111,111 shares issuable upon conversion of 888,888 shares of Series I Convertible Preferred Stock, and 51,724 shares issuable upon conversion of 600 shares of Series H Convertible Preferred Stock.
  • No company proceeds: According to the filing, Cycurion will not receive any proceeds from the resale of shares by the selling stockholders.
  • Reverse stock split: On August 28, 2026, the company effected a 1-for-8 reverse stock split of its issued and outstanding shares of common stock.
  • Common stock closing price: On November 9, 2026, the closing sale price of the common stock was $2.47, as stated in the prospectus.
  • Company classification: Cycurion disclosed that it is a non-accelerated filer, a smaller reporting company, and an emerging growth company.

Cycurion's S-1 Amendment: Resale Structure and Key Transactions

Cycurion, Inc. (NASDAQ:CYCU), a Delaware-incorporated company with its principal offices in McLean, Virginia, submitted Amendment No. 1 to its Form S-1 registration statement on November 10, 2026, under File No. 333-297262. The filing registers the resale of up to 789,355 shares of common stock on behalf of selling stockholders, with Armistice Capital Master Fund Ltd. identified as a primary selling stockholder. The company stated that common stock is listed on The Nasdaq Global Market and its warrants are listed on The Nasdaq Capital Market under the symbols "CYCU" and "CYCUW," respectively.

The 789,355 shares span three categories tied to separate transactions. The 626,520 warrant shares arise from what the prospectus describes as "The Warrant Inducement Transaction" with Armistice. The 111,111 shares linked to Series I Convertible Preferred Stock relate to a "Merger Agreement with Secuvant," while the 51,724 shares tied to Series H Convertible Preferred Stock relate to "The Cycurion Digital Ally Acquisition," according to the filing. The company disclosed that shares issued or issuable to Armistice under the inducement agreement were or may be issued in private placements exempt from Securities Act registration requirements, and the S-1 amendment is intended to satisfy registration rights granted to the selling stockholders.

The filing noted that all share amounts, per-share amounts, exercise prices, conversion prices, and other share-based information in the prospectus have been retroactively adjusted for the August 28, 2026 1-for-8 reverse stock split, with the exception of financial statements incorporated from the company's Annual Report on Form 10-K for the year ended December 31, 2025, and Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which have not been retrospectively adjusted. Cycurion disclosed it will bear all registration costs, while selling stockholders will bear any sales commissions or discounts.

What Was Disclosed

Cycurion filed Amendment No. 1 to Form S-1 on November 10, 2026, registering up to 789,355 resale shares across three selling stockholder tranches connected to a warrant inducement transaction, a Secuvant merger, and a Digital Ally acquisition. The company will receive no proceeds from the resales.